Lv4
460 积分 2021-06-08 加入
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial
1天前
已完结
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
1天前
已完结
Intraperitoneal chemotherapy for ovarian cancer using sustained-release implantable devices
2天前
已完结
Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: A meta-analysis
2天前
已完结
Intraperitoneal Chemotherapy
2天前
已完结
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer
2天前
已完结
Intraperitoneal chemotherapy requires expertise and should be the standard of care for optimally surgically resected epithelial ovarian cancer patients
2天前
已完结
The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis
2天前
已完结
Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study
2天前
已完结
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
2天前
已完结
皖公网安备34019202002308
